Page 31 - Omnipod System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Omnipod system. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Omnipod System Today - Breaking & Trending Today

StockNews.com Begins Coverage on Insulet (NASDAQ:PODD)

StockNews.com started coverage on shares of Insulet (NASDAQ:PODD – Get Rating) in a research note issued to investors on Thursday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock. Several other research analysts have also weighed in on PODD. Stifel Nicolaus upped their target price on shares of Insulet from $300.00 […] ....

Wayded Mcmillan , Robertw Baird , Piper Sandler , Stifel Nicolaus , Raymond James , Charles Alpuche , Moneta Group Investment Advisors , Gateway Advisory , Clearbridge Investments , Wolfe Research , Geode Capital Management , Norges Bank , Insulet Corp , Get Rating , Group Investment Advisors , Capital Management , Omnipod System , Insulet Daily , Nasdaq Podd , Initiated Coverage , Stocknews Com ,

Weekly Investment Analysts' Ratings Changes for Insulet (PODD)

Insulet (NASDAQ: PODD) recently received a number of ratings updates from brokerages and research firms: 5/18/2023 – Insulet is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/8/2023 – Insulet had its price target raised by analysts at Barclays PLC from $292.00 to $329.00. 5/5/2023 – Insulet had its […] ....

United States , New York , Piper Sandler , Robertw Baird , Charles Alpuche , Wayded Mcmillan , Stifel Nicolaus , News Ratings For Insulet Co Daily , Barclays Plc , Quintet Private Bank Europe , Insulet Corp , First Manhattan Co , American National Bank , Insulet Co , Lindbrook Capital , Get Rating , National Bank , Omnipod System , Insulet Co Daily , Nasdaq Podd ,

William Blair Investment Management LLC Sells 200,951 Shares of Insulet Co. (NASDAQ:PODD)

William Blair Investment Management LLC cut its position in Insulet Co. (NASDAQ:PODD – Get Rating) by 40.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 301,601 shares of the medical instruments supplier’s stock after selling 200,951 shares during the quarter. William […] ....

Robertw Baird , Charles Alpuche , Wayded Mcmillan , Raymond James , Huntington National Bank , Insulet Co , Insulet Corp , Bessemer Group Inc , Wolfe Research , Exchange Commission , William Blair Investment Management , Wipfli Financial Advisors , Insulet Company Profile , Get Rating , Blair Investment Management , National Bank , Financial Advisors , Spartan Planning , Wealth Management , Stock Down , Omnipod System , Visit Holdingschannel , Insulet Daily , Nasdaq Podd , Sec Filings , Hedge Fund Holdings ,

LGT Group Foundation Sells 3,388 Shares of Raytheon Technologies Co. (NYSE:RTX)

Motley Fool Asset Management LLC lessened its position in shares of Insulet Co. (NASDAQ:PODD – Get Rating) by 7.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,261 shares of the medical instruments supplier’s stock after selling 103 shares during the quarter. Motley […] ....

Stifel Nicolaus , Wayded Mcmillan , Charles Alpuche , Robertw Baird , Piper Sandler , Clearbridge Investments , Securities Exchange Commission , Lord Abbett , Morgan Stanley , Victory Capital Management Inc , Motley Fool Asset Management , Renaissance Technologies , Insulet Corp , Insulet Co , Scout Investments Inc , Get Rating , Fool Asset Management , Victory Capital Management , Capital Management , Exchange Commission , Trading Down , Omnipod System , Visit Holdingschannel , Insulet Daily , Nasdaq Podd , Sec Filings ,

Insulet (NASDAQ:PODD) Price Target Increased to $329.00 by Analysts at Barclays

Insulet (NASDAQ:PODD – Get Rating) had its price objective upped by Barclays from $292.00 to $329.00 in a research report report published on Monday morning, The Fly reports. Several other research firms have also recently weighed in on PODD. Raymond James increased their price target on shares of Insulet from $320.00 to $334.00 and gave […] ....

Charles Alpuche , Raymond James , Piper Sandler , Robertw Baird , Wayded Mcmillan , Insulet Corp , Ameritas Investment Partners Inc , Intech Investment Management , Insulet Company Profile , Vanguard Personalized Indexing Management , Securities Exchange Commission , Advisor Group , Sohn Co , Get Rating , Exchange Commission , Investment Management , Investment Partners , Personalized Indexing Management , Omnipod System , Insulet Daily , Nasdaq Podd , Boost Price Target , Barclays Plc ,